About | Free Trial

Last Update

2008-11-14T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Background Information

Employment History

Independent Scientist
San Raffaele Scientific Institute

Web References (12 Total References)


AllergoOncology Portal - Luca Vangelista

www.allergooncology.org [cached]

Luca Vangelista AllergoOncology Portal - Luca Vangelista

...
Luca Vangelista
...
Dr. Luca Vangelista San Raffaele Scientific Institute
...
Dr. Luca Vangelista spent over a decade in several European laboratories, in the commitment to characterize molecular and structural biology aspects of IgE, FceRI and recombinant allergens. In 2003 he moved to Milan where he joined Prof. Antonio Siccardi as an independent Scientist at the San Raffaele Scientific Institute and the Department of Biology and Genetics of the University of Milan. He is developing innovative strategies to combat tumors using exogenous IgE and its derivatives and is investigating the role of endogenous IgE in tumor surveillance.


Microbicides 2008: Third-generation microbicides might act as ‘bacterial vaccine’ — Microbicides Media and Communications Initiative

www.mmci-communications.org [cached]

Finally, in experiments combining both approaches, Luca Vangelista of the San Raffaele Scientific Institute in Italy has engineered the same lactobacilli as in the Xu study to produce human-type RANTES and is currently engineering another variant that will produce an analogue called C1C5-RANTES, and also small peptides - sections - derived from RANTES to see if these have anti-HIV activity.


BCPWA HIV/AIDS eNews - March 14, 2008

bcpwa.baremetal.com [cached]

Finally, in experiments combining both approaches, Luca Vangelista of the San Raffaele Scientific Institute in Italy has engineered the same lactobacilli as in the Xu study to produce human-type RANTES and is currently engineering another variant that will produce an analogue called C1C5-RANTES, and also small peptides , sections , derived from RANTES to see if these have anti-HIV activity.


Finally, in experiments combining both ...

www.aidsmap.org [cached]

Finally, in experiments combining both approaches, Luca Vangelista of the San Raffaele Scientific Institute in Italy has engineered the same lactobacilli as in the Xu study to produce human-type RANTES and is currently engineering another variant that will produce an analogue called C1C5-RANTES, and also small peptides - sections - derived from RANTES to see if these have anti-HIV activity.


Aidsmap | Microbicides 2008: Third-generation microbicides might act as ‘bacterial vaccine’

www.nam.org.uk [cached]

Finally, in experiments combining both approaches, Luca Vangelista of the San Raffaele Scientific Institute in Italy has engineered the same lactobacilli as in the Xu study to produce human-type RANTES and is currently engineering another variant that will produce an analogue called C1C5-RANTES, and also small peptides - sections - derived from RANTES to see if these have anti-HIV activity.

Similar Profiles

Other People with this Name

Other people with the name Vangelista

Dianne Vangelista
Hocking Stuart

Ken Vangelista
Northrop Grumman Corporation

Alberto Vangelista
Politecnico di Torino

Michele Vangelista
CROMSOURCE Inc

Lorenzo Vangelista
University of Padova

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory